Telomeres, telomerase, and cancer: life on the edge of genomic stability
- 1 January 2000
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Oncology
- Vol. 12 (1) , 74-81
- https://doi.org/10.1097/00001622-200001000-00013
Abstract
The presence of telomerase activity in most human tumors, but not in many normal somatic tissues, has raised considerable interest in telomerase as a possible anticancer therapy. Recent advances in the cloning and characterization of mammalian telomerase components have paved the way for a more detailed understanding of the role of telomerase and telomere length maintenance in cell proliferation. Here, we summarize the most recent biochemical and genetic evidence suggesting that telomere length maintenance by telomerase is critical to the proliferative ability of some immortalized mammalian cells in culture and in vivo.Keywords
This publication has 73 references indexed in Scilit:
- Mammalian Telomeres End in a Large Duplex LoopCell, 1999
- Normal human chromosomes have long G-rich telomeric overhangs at one endGenes & Development, 1997
- Human telomeres contain two distinct Myb–related proteins, TRF1 and TRF2Nature Genetics, 1997
- The terminal DNA structure of mammalian chromosomesThe EMBO Journal, 1997
- Control of telomere length by the human telomeric protein TRF1Nature, 1997
- TELOMERE LENGTH REGULATIONAnnual Review of Biochemistry, 1996
- A Human Telomeric ProteinScience, 1995
- Human telomeres contain at least three types of G–rich repeat distributed non-randomlyNucleic Acids Research, 1989
- A theory of marginotomyJournal of Theoretical Biology, 1973
- Sugar and DiseaseNature, 1972